Thomson Reuters | Competitive Intelligence

Science

Featured Product

Thomson Reuters Pharma

Competitor intelligence database integrating more than 40 pharmaceutical data sources, unique abstracts, commentaries and analysis. Learn more about Thomson Reuters Pharma.

CMR Factbook

Yearly publication of reliable, authoritative pharmaceutical performance metrics and trends analysis from CMR International.

Newport Premium (for Generics)

By incorporating the unique strategic intelligence and powerful competitive analysis that is only available from Thomson Reuters, we help you be first to find the drug, first to find the niche, first to make the deal, and first to get to market. Optional add-on modules covering phase III drugs, generic industry deals, and US market statistics are also available.

Newport Premium (for Innovators)

If you’re an innovator, we can give you up to seven years’ advance warning of generic product development activities, patent challenges and attempts at patent circumvention. Our powerful competitive intelligence and analytical tools can help you identify, assess and track the earliest signs of generic competition. Optional add-on modules covering generic industry deals, and US market statistics are also available.

Pathway Map Creator

Quickly and easily create, customize, and publish Pathway Maps.

Pipeline Data Integrator

Powerful data integration service that enables you to search seamlessly across the major drug pipeline databases.

Thomson Reuters Partnering

Offers you a comprehensive look at drugs currently in development, the companies developing them, and their market potential.

Thomson Reuters Cortellis for Competitive Intelligence

All the data you need for a complete picture of the pharmaceutical competitive landscape from one source.

Thomson Reuters Drug News

Thomson Reuters Drug News selects the latest, most important drug discovery and development news, places it in context, and presents it online and as email alerts in a clear, concise format that makes it easy to discover the important facts at a glance.

Thomson Reuters Integrity

Thomson Reuters Integrity SM provides researchers with reliable, detailed information across multiple disciplines and from the perspective of a scientist – to support successful drug research and development.Integrating biology, chemistry and pharmacology data on more than 320,000 compounds with demonstrated biological activity and almost 140,000 patent family records, Integrity provides a unique knowledge solution designed to empower your discovery and development activities where you need it most – at the bench.